Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Event Phase 2 Rate (12 mg group) Phase 2 Rate (Placebo) Nausea 45.8% 11.6% Diarrhea 33.3% 9.3% Vomiting 22.2% 2.3% Constipation 16.7% 7.0% Decreased appetite 22.2% 2.3% The nausea incidence at the highest dose a nausea percentage of roughly 46% makes it the single most reported adverse event in retatrutide clinical trials 2026 data
Drug Formulary Information Select how you want to search for your formulary
You might experience some brief stinging or burning at the injection site, or minor irritation
The ordinary white sugar we eat is rapidly absorbed in the upper part of the small intestine, leaving no chance for it to reach the deeper regions of the gut and interact with these receptors
US$ 27.21
US$ 28.69
US$ 29.61
